Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody
Authors
Schiller, ZacharyToomey, Jacqueline R.
Monir, Ejemel
Souders, Colby A.
Peterson, Eric
Cannon, Rebecca D.
Ganesa, Chandrashekar
Fazio, Frank
Mantis, Nicholas J.
Cavacini, Lisa A.
Sullivan-Bolyai, John
Klempner, Mark S.
Wang, Yang
UMass Chan Affiliations
MassBiologicsDocument Type
Journal ArticlePublication Date
2021-06-01Keywords
Bacterial infectionsBacterial vaccines
Immunology
Infectious disease
Bacterial Infections and Mycoses
Immunology of Infectious Disease
Immunoprophylaxis and Therapy
Infectious Disease
Metadata
Show full item recordAbstract
Disrupting transmission of Borrelia burgdorferi sensu lato complex (B. burgdorferi) from infected ticks to humans is one strategy to prevent the significant morbidity from Lyme disease. We have previously shown that an anti-OspA human mAb, 2217, prevents transmission of B. burgdorferi from infected ticks in animal models. Maintenance of a protective plasma concentration of a human mAb for tick season presents a significant challenge for a preexposure prophylaxis strategy. Here, we describe the optimization of mAb 2217 by amino acid substitutions (2217LS: M428L and N434S) in the Fc domain. The LS mutation led to a 2-fold increase in half-life in cynomolgus monkeys. In a rhesus macaque model, 2217LS protected animals from tick transmission of spirochetes at a dose of 3 mg/kg. Crystallographic analysis of Fab in complex with OspA revealed that 2217 bound an epitope that was highly conserved among the B. burgdorferi, B. garinii, and B. afzelii species. Unlike most vaccines that may require boosters to achieve protection, our work supports the development of 2217LS as an effective preexposure prophylaxis in Lyme-endemic regions, with a single dose at the beginning of tick season offering immediate protection that remains for the duration of exposure risk.Source
Schiller ZA, Rudolph MJ, Toomey JR, Ejemel M, LaRochelle A, Davis SA, Lambert HS, Kern A, Tardo AC, Souders CA, Peterson E, Cannon RD, Ganesa C, Fazio F, Mantis NJ, Cavacini LA, Sullivan-Bolyai J, Hu LT, Embers ME, Klempner MS, Wang Y. Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody. J Clin Invest. 2021 Jun 1;131(11):e144843. doi: 10.1172/JCI144843. PMID: 33914704; PMCID: PMC8159683. Link to article on publisher's site
DOI
10.1172/JCI144843Permanent Link to this Item
http://hdl.handle.net/20.500.14038/41994PubMed ID
33914704Notes
Full author list omitted for brevity. For the full list of authors, see article.
Related Resources
ae974a485f413a2113503eed53cd6c53
10.1172/JCI144843